Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. Home

How to use endocrine therapy in premenopausal women with ER+ early breast cancer

In this 'How To' educational video, Fatima Cardoso explains how to use endocrine therapy in premenopausal women with ER-positive, HER2-negative early breast cancer. Risk characteristics and patient compliance are important factors when proposing and selecting treatment together with the patient.

Reprinted by permission from Springer Nature: D.L. Hershman et al., Breast Cancer Res Treat. 2011 Apr;126(2):529-37

Authors

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.